Our Take
Equity-for-grants is industrial policy, not venture capital, and the IonQ exclusion reveals real political friction beneath the quantum narrative.
Why it matters
Quantum remains pre-commercial and error-prone, yet the US is now a direct shareholder in the sector's viable players. That concentration of state ownership reshapes funding dynamics and raises hard questions about which technical bets the government backs when the science itself is unsettled.
Do this week
Quantum vendors: audit your government-funding pipeline and political exposure now, before valuations get locked into these equity deals.
Nine quantum startups signed letters of intent with the US Commerce Department on Thursday to accept $2 billion in equity stakes in exchange for federal grants. The move follows a precedent set in 2025 when the same administration converted $2.2 billion in CHIPS Act grants into a 10 percent stake in Intel, plus $8.9 billion in additional federal funding that had been awarded but not yet paid (per Commerce Department announcement).
The beneficiaries of the quantum deal remain unnamed in the administration's Thursday announcement, but notable for its absence is IonQ, one of the sector's most-funded private quantum companies. IonQ has attracted significant investment from Cerberus Capital Management, co-founded by Stephen Feinberg, who serves as Trump's deputy secretary of war.
The administration framed the investment as strategic workforce and capability building. A Trump official stated the move would "build on our domestic industry, creating thousands of high-paying American jobs while advancing American quantum capabilities." The deals are not yet final; the Commerce Department said it remains open to proposals from other advanced tech firms.
Separately, one previously disclosed grant recipient offers political texture: Vulcan Elements, a rare-earths startup with roughly 30 employees, received a federal investment despite Trump Jr.'s venture capital firm holding a stake. The inclusion signals the administration's willingness to support strategic sectors tied to broader political and family networks.
This is not a private venture capital round. It is state ownership of quantum infrastructure at a moment when the technology remains scientifically contested and commercially unproven.
Quantum computers exploit atomic-level phenomena to theoretically perform calculations faster than classical machines. But significant engineering hurdles remain unsolved: error correction, qubit stability, and the open competition over which technical approaches (superconducting qubits, trapped ions, photonic systems) will win are still unresolved. The field has no consensus winner.
By taking equity stakes rather than issuing grants alone, the federal government becomes a direct stakeholder in the success of nine chosen firms. That creates three second-order effects:
- It concentrates public capital behind a small cohort of vendors, potentially starving alternative approaches and reducing technical diversity in a field where the right path forward is unknown.
- It locks the government into those nine firms' valuations and financial fortunes, creating political pressure to keep them solvent even if their technical approach falters.
- It signals to other countries, notably the UK (which is also increasing quantum investment), that the US is willing to deploy state capital aggressively in this sector. That provokes arms-race dynamics.
The IonQ exclusion cuts deeper. IonQ is well-capitalized and technically respectable, yet the administration declined to include it despite Feinberg's White House role. That gap suggests either internal Trump-administration friction over vendor selection, or a deliberate choice to exclude a Cerberus-backed firm in favor of firms with different political sponsorship. Either reading undermines the "purely strategic" framing.
Quantum vendors who received or are pursuing federal funding should expect government involvement in board decisions, capital allocation, and strategic pivots as valuations harden. Intel's post-deal shareholder lawsuit (company-reported) already signals litigation risk when equity stakes create conflicts between public interest and shareholder return.
For companies outside the nine selected firms: this deal freezes venture capital appetite for quantum startups not blessed by Commerce. The private market will defer to federal priority. Expect a 12-to-24-month funding gap for quantum vendors outside the government cohort, regardless of technical merit.